Results 51 to 60 of about 264,610 (150)

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies

Gut and Liver
Background/Aims: Noninvasive indexes can be used to diagnose and stage liver fibrosis caused by chronic hepatitis B (CHB). We aimed to evaluate whether changes in the liver stiffness measurement (LSM) and serum biomarkers can predict liver fibrosis ...
Jiayi Zhang, Shuyan Chen, Jialing Zhou, Bingqiong Wang, Xiaoning Wu, Xiaoqian Xu, Xinyu Zhao, Yuanyuan Kong, Xiaojuan Ou, Yameng Sun, Hong You   +10 more
doaj   +1 more source

Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis

Gastroenterology Research and Practice, 2019
Objective. The diagnostic value of antinuclear antibodies (ANAs) including anti-gp210 and anti-sp100 for primary biliary cholangitis/cirrhosis (PBC) has been widely reported.
Qian Zhang, Zhiqiang Liu, Shanshan Wu, Weijia Duan, Sha Chen, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia   +8 more
doaj   +1 more source

The BTLA/HVEM axis as a key regulator for stratified functional cure in chronic hepatitis B

Frontiers in Immunology
BackgroundFunctional cure rates in chronic hepatitis B (CHB) remain below 10% after long-term nucleos(t)ide analogue (NA) therapy, and PD-1/PD-L1 blockade achieves HBsAg clearance in approximately 30% of selected patients with low baseline HBsAg (≤100 IU/
Yuzhen Zhang, Shuqi Yang, Yanyan Lin, Yanyan Qiu, Xueping Yu, Xueping Yu   +5 more
doaj   +1 more source

Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study

Surgery Open Science
Aims: To evaluate the efficacy of re-resection in recurrent hepatocellular carcinoma (rHCC), identify prognostic factors, and provide clinical guidance.
Qi Fan, MM, Pengcheng Wei, MM, Delin Ma, MD, Qian Cheng, MD, Jie Gao, MD, Jiye Zhu, MD, Zhao Li, MD   +6 more
doaj   +1 more source

Laennec's cirrhosis [PDF]

The Lancet, 2019
openaire   +2 more sources

Hepatoma in Cirrhosis [PDF]

BMJ, 1963
S G, ELKINGTON, D J, MCBRIEN, H, SPENCER
openaire   +2 more sources

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD [PDF]

Clinical and Molecular Hepatology, 2013
Wonseok Kang, Seung Up Kim
doaj   +1 more source

QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis

JHEP Reports
Background & Aims: QuickStroop, a shortened version of the Stroop EncephalApp, has recently been proposed for screening for minimal hepatic encephalopathy (MHE) in patients with cirrhosis in the USA.
Christian Labenz, Simon J. Gairing, Leonard Kaps, Alena F. Ehrenbauer, Eva M. Schleicher, Sophie Mengel, Julius F.M. Egge, Maria M. Gabriel, Peter R. Galle, Heiner Wedemeyer, Alexander Zipprich, Cristina Ripoll, Robin Greinert, Benjamin Maasoumy   +13 more
doaj   +1 more source

Stories behind the cover

Portal Hypertension & Cirrhosis, 2023
Editorial Office
doaj   +1 more source

Cirrhosis of the Liver [PDF]

Postgraduate Medical Journal, 1950
openaire   +3 more sources